The Lung Cancer Foundation's

LungBlog

An up-to-the-minute dose of health and hope for lung cancer

 

Archive for March, 2008

UCB considers partner for lung cancer drug CDP791; reports ‘positive’ phase 2

lc1.jpgUCB SA. said it considering finding a partner for the development of its lung cancer drug CDP791 and reported ‘positive’ trends from second phase clinical trials.

 

No Comments | Trackback | Permalink

 

Lung cancer treatment adds 2 years

 

No Comments | Trackback | Permalink

 

Moffitt cancer center bans smoking on its grounds

 

No Comments | Trackback | Permalink

 

Differences in IMRT Radiation Doses May Complicate Study Results in Lung Cancer

 

No Comments | Trackback | Permalink

 

Climbing the tortuous stairway to charity leaves a virtuous pride

 

No Comments | Trackback | Permalink

 

Radon: The Silent Home Invader That Can Kill

 

No Comments | Trackback | Permalink

 

A Doctor’s Journey with Cancer

 

No Comments | Trackback | Permalink

 

Lung cancer death in women increases

 

No Comments | Trackback | Permalink

 

Last-chance drugs give hope to cancer patients

 

No Comments | Trackback | Permalink

 

Employees aim for new heights at cancer event

 

No Comments | Trackback | Permalink